Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Most Profitable Second Quarter Biotech Stocks
Most Profitable Second Quarter Biotech Stocks
Most Profitable Second Quarter Biotech Stocks
Submitted by
admin
on April 2, 2013 - 10:58am
Source:
TheStreet.com
News Tags:
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Headline:
Most Profitable Second Quarter Biotech Stocks
Do Not Allow Advertisers to Use My Personal information